Department of Health Services, University of Washington, 1959 NE Pacific St, Magnuson Health Sciences Center, Room H-680, Seattle, WA, 98195-7660, United States; Department of Global Health, University of Washington, Harris Hydraulics Laboratory, Box 357965, Seattle, WA, 98195-7965, United States.
Department of Global Health, University of Washington, Harris Hydraulics Laboratory, Box 357965, Seattle, WA, 98195-7965, United States; Department of Psychiatry and Behavioral Sciences, University of Washington, 1959 NE Pacific Street, Box 356560, Room BB1644, Seattle, WA, 98195-6560, United States.
Drug Alcohol Depend. 2020 Jan 1;206:107753. doi: 10.1016/j.drugalcdep.2019.107753. Epub 2019 Nov 20.
BACKGROUND: Alcohol use is common among people living with HIV and negatively impacts care and outcomes. African-American women living with HIV are subject to vulnerabilities that may increase risk for alcohol use and associated HIV-related outcomes. METHODS: We used baseline data from a randomized controlled trial of an HIV-related stigma-reduction intervention among African-American women living with HIV in Chicago and Birmingham (2013-2015). Patterns of alcohol use [any use, unhealthy alcohol use (UAU), heavy episodic drinking (HED)] were measured using the AUDIT-C. We assessed demographic, social, and clinical characteristics which may influence alcohol use and HIV-related outcomes which may be influenced by patterns of alcohol use in bivariate and multivariable analyses. RESULTS: Among 220 African-American women living with HIV, 54 % reported any alcohol use, 24 % reported UAU, and 27 % reported HED. In bivariate analysis, greater depressive symptoms, lower religiosity, lower social support, marijuana, and crack/cocaine use were associated with patterns of alcohol use (p < 0.05). Marijuana and cocaine/crack use were associated with patterns of alcohol use in adjusted analysis (p < 0.05). In adjusted analysis, any alcohol use and HED were associated with lower likelihood of ART adherence (ARR = 0.72, 95 % CI: 0.53-0.97 and ARR = 0.65, 95 % CI: 0.44-0.96, respectively), and UAU was associated with lack of viral suppression (ARR = 0.78, 95 % CI: 0.63-0.96). CONCLUSIONS: Findings suggest any and unhealthy alcohol use is common and associated with poor HIV-related outcomes in this population. Regular alcohol screening and intervention should be offered, potentially targeted to subgroups (e.g., those with other substance use).
背景:在感染艾滋病毒的人群中,饮酒是很常见的,这会对护理和结果产生负面影响。感染艾滋病毒的非裔美国女性面临着各种脆弱性,这可能会增加她们饮酒的风险,以及与艾滋病毒相关的不良后果。
方法:我们使用了 2013 年至 2015 年在芝加哥和伯明翰开展的一项针对感染艾滋病毒的非裔美国女性的与艾滋病毒相关耻辱感减少干预措施的随机对照试验的基线数据。使用 AUDIT-C 测量饮酒模式[任何使用、不健康饮酒(UAU)、重度间歇性饮酒(HED)]。评估了可能影响饮酒模式的人口统计学、社会和临床特征,以及可能受到饮酒模式影响的与艾滋病毒相关的结果,在单变量和多变量分析中进行了评估。
结果:在 220 名感染艾滋病毒的非裔美国女性中,54%报告有任何饮酒,24%报告有 UAU,27%报告有 HED。在单变量分析中,更多的抑郁症状、更低的宗教信仰、更低的社会支持、大麻和快克可卡因的使用与饮酒模式相关(p<0.05)。大麻和快克可卡因的使用与调整后的分析中的饮酒模式相关(p<0.05)。在调整后的分析中,任何饮酒和 HED 与较低的 ART 依从率相关(ARR=0.72,95%CI:0.53-0.97 和 ARR=0.65,95%CI:0.44-0.96),UAU 与缺乏病毒抑制相关(ARR=0.78,95%CI:0.63-0.96)。
结论:这些发现表明,在该人群中,任何饮酒和不健康饮酒都很常见,并且与较差的艾滋病毒相关结果相关。应定期提供酒精筛查和干预,可能针对特定亚组(例如,有其他物质使用的人群)。
J Acquir Immune Defic Syndr. 2019-6-1
J Acquir Immune Defic Syndr. 2018-7-1
J Racial Ethn Health Disparities. 2020-2
AIDS Behav. 2024-2
JAMA. 2019-3-5
Curr HIV/AIDS Rep. 2019-2
J Acquir Immune Defic Syndr. 2018-7-1
Curr Opin Infect Dis. 2018-2
Addict Sci Clin Pract. 2017-9-27